Compare, Analyse Orchid Chemicals with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ACTAVIS (US) - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ACTAVIS
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ACTAVIS
Dec-18
ORCHID PHARMA LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs19413,781-   
Low Rs359,244-   
Sales per share (Unadj.) Rs276.53,380.5-  
Earnings per share (Unadj.) Rs-79.2-1,088.9-  
Cash flow per share (Unadj.) Rs-43.5356.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.913,942.9-  
Shares outstanding (eoy) m70.45332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.43.4 12.2%   
Avg P/E ratio x-1.4-10.6 13.7%  
P/CF ratio (eoy) x-2.632.3 -8.2%  
Price / Book Value ratio x2.10.8 257.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0673,829,128 0.2%   
No. of employees `0002.816.9 16.6%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.166,529.6 10.5%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0-21,429.2 9.3%   
INCOME DATA
Net Sales Rs m19,4771,124,350 1.7%  
Other income Rs m40721,501 1.9%   
Total revenues Rs m19,8841,145,851 1.7%   
Gross profit Rs m1,10329,464 3.7%  
Depreciation Rs m2,519480,635 0.5%   
Interest Rs m5,22764,881 8.1%   
Profit before tax Rs m-6,236-494,552 1.3%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511126,131 0.4%   
Tax Rs m-125-6,267 2.0%   
Profit after tax Rs m-5,580-362,154 1.5%  
Gross profit margin %5.72.6 216.0%  
Effective tax rate %2.01.3 158.4%   
Net profit margin %-28.7-32.2 88.9%  
BALANCE SHEET DATA
Current assets Rs m11,014461,150 2.4%   
Current liabilities Rs m32,060407,948 7.9%   
Net working cap to sales %-108.14.7 -2,283.6%  
Current ratio x0.31.1 30.4%  
Inventory Days Days9520 484.5%  
Debtors Days Days3466 50.6%  
Net fixed assets Rs m29,440127,270 23.1%   
Share capital Rs m7050-   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8004,637,419 0.1%   
Long term debt Rs m9,0181,633,003 0.6%   
Total assets Rs m46,5107,249,341 0.6%  
Interest coverage x-0.2-6.6 2.9%   
Debt to equity ratio x2.40.4 673.9%  
Sales to assets ratio x0.40.2 270.0%   
Return on assets %-0.8-4.1 18.5%  
Return on equity %-146.9-7.8 1,880.5%  
Return on capital %-3.7-4.8 77.1%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682401,688 0.4%  
From Investments Rs m-9,860220,675 -4.5%  
From Financial Activity Rs m6,644-689,417 -1.0%  
Net Cashflow Rs m-1,535-66,719 2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare ORCHID PHARMA LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: ALEMBIC PHARMA  VENUS REMEDIES  DR. REDDYS LAB  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS